26 Mar 2026 · 3 min read
Earendil Labs just raised $787M for AI-driven biologics. The largest AI biotech round of 2026 so far.
A company you’ve most likely never heard of just raised $787M for AI-driven biologics. The headline number is striking. Sanofi’s trajectory — partner to repeat customer to investor in under twelve months — tells you more about the platform than any press release. The Delaware-incorporated, Beijing-operating structure is the emerging architecture for Chinese AI biotech going global.